Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms

Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms

ObjectiveIt is vital to enhance the identification of early recurrence in intrahepatic cholangiocarcinoma (ICC) patients after curative-intent resection and to determine which patients could benefit from adjuvant chemotherapy (ACT). This study aimed to evaluate the effectiveness of machine learning...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Li, Hengchao Liu, Yubo Ma, Zhenqi Tang, Chen Chen, Dong Zhang, Zhimin Geng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
intrahepatic cholangiocarcinoma
recurrence
prognosis
machine learning
adjuvant chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1594200/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items